Evaluating extended-release calcifediol as a treatment option for chronic kidney disease-mineral and bone disorder (CKD-MBD) November 2019 | PubMed
Rationale for Raising Current Clinical Practice Guideline Target for Serum 25-Hydroxyvitamin D in Chronic Kidney Disease March 2019 | PubMed
Extended-release calcifediol for secondary hyperparathyroidism in stage 3-4 chronic kidney disease September 2017 | PubMed
Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques September 2017 | Science
Calcifediol to treat secondary hyperparathyroidism in patients with chronic kidney disease September 2017 | PubMed
Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease September 2016 | PubMed